Popular Trials
Radiation Therapy
Stereotactic Radiosurgery for Spinal Cord Compression
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a one-time high-dose radiation treatment called Spine Stereotactic Radiosurgery (SSRS) for patients with spinal cord compression from cancer who can't have surgery. The goal is to see if this precise treatment can stop tumor growth and prevent spinal cord injury. Patients will be monitored regularly to check their progress. Spine stereotactic radiosurgery (SSRS) is increasingly being used to treat metastatic spinal tumors and has shown high rates of local tumor control.
Checkpoint Inhibitor
Nivolumab +/− Stereotactic Radiosurgery for Chordoma
Recruiting1 awardPhase 1
Baltimore, Maryland
This trial is studying nivolumab with or without SRS to treat patients with chordoma. Nivolumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. SRS is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor.
Radiation Therapy
Radiosurgery for Trigeminal Neuralgia
Recruiting1 award6 criteria
Birmingham, Alabama
This trial is testing a new type of non-invasive surgery that uses precise radiation to treat severe facial pain. It targets patients with trigeminal neuralgia who may not respond to other treatments. The goal is to see if this method can effectively reduce or stop their pain.
Popular Filters
Trials for Adenocarcinoma Patients
Radiation Therapy
Stereotactic Radiotherapy for Lung Cancer
Recruiting1 awardPhase 2
Toronto, Ontario
This trial is testing SBRT, a precise radiation treatment for lung tumors. It targets tumors with high doses from multiple angles to shrink them and control cancer growth. The treatment is aimed at patients with lung cancer and metastases. SBRT, also known as stereotactic ablative radiotherapy (SABR), is a precise radiation treatment developed originally for intracranial targets and now widely used for treating lung tumors and metastases.
Radiation
CAN-2409 + Chemoradiation/SBRT for Pancreatic Cancer
Recruiting1 awardPhase 2
Fort Myers, Florida
This trial is testing a new immunotherapy treatment for pancreatic cancer that has shown promise in earlier trials. The new treatment will be given in combination with standard chemotherapy and radiation, and the goal is to see if it improves outcomes for patients with pancreatic cancer.
Trials for NSCLC Patients
Radiation Therapy
Stereotactic Radiotherapy for Lung Cancer
Recruiting1 awardPhase 2
Toronto, Ontario
This trial is testing SBRT, a precise radiation treatment for lung tumors. It targets tumors with high doses from multiple angles to shrink them and control cancer growth. The treatment is aimed at patients with lung cancer and metastases. SBRT, also known as stereotactic ablative radiotherapy (SABR), is a precise radiation treatment developed originally for intracranial targets and now widely used for treating lung tumors and metastases.
Radiation
Stereotactic Ablative Radiosurgery for Lung Cancer
Recruiting1 award11 criteria
Winnipeg, Manitoba
This trial is for patients with early stage lung cancer or a single pulmonary metastasis. Three tumor locator beacons are placed in the small bronchial airways near the tumors. This allows for smaller treatment volumes of Stereotactic Ablative Radiosurgery (SABR) and more precise delivery of radiotherapy.
Radiation Therapy
SBRT for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1
Vancouver, British Columbia
This trial tests different levels of radiation to find the safest high dose for patients with high-risk ultracentral tumors. It uses a method that adjusts doses based on patient responses to minimize severe side effects.
Monoclonal Antibodies
Durvalumab + SBRT for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Providence, Rhode Island
This trial is testing a combination of two treatments, Durvalumab and stereotactic body radiation therapy (SBRT), to see if it is more effective in fighting lung cancer than Durvalumab alone.
Phase 3 Trials
Radiation Therapy
Radiosurgery vs Whole Brain Radiation for Brain Metastasis
Recruiting2 awardsPhase 3
Houston, Texas
This trial compares two radiation treatments for brain tumors from non-melanoma cancers. One treatment is a focused, high-dose method, while the other treats the entire brain over several sessions. The goal is to determine which method controls tumors better and has fewer side effects on thinking and memory. The focused, high-dose method has been increasingly used over the past years as an effective treatment for brain metastases, often replacing the whole brain treatment due to its ability to improve outcomes and reduce side effects.
Radiation
Stereotactic Radiosurgery vs. HA-WBRT + Memantine for Brain Cancer
Recruiting2 awardsPhase 3
Tucson, Arizona
This trial is testing whether memantine used in combination with HA-WBRT helps to improve mental function (measured by how well patients can remember things) compared to those who receive HA-WBRT alone.
Trials With No Placebo
Radiation Therapy
Stereotactic Radiosurgery for Brain Tumors
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial aims to study the side effects and determine the optimal dose of a type of radiation therapy called stereotactic radiosurgery for treating patients with large brain metastases. Radiosurgery targets the tumor
Radiation Therapy
Stereotactic Radiotherapy for Lung Cancer
Recruiting1 awardPhase 2
Toronto, Ontario
This trial is testing SBRT, a precise radiation treatment for lung tumors. It targets tumors with high doses from multiple angles to shrink them and control cancer growth. The treatment is aimed at patients with lung cancer and metastases. SBRT, also known as stereotactic ablative radiotherapy (SABR), is a precise radiation treatment developed originally for intracranial targets and now widely used for treating lung tumors and metastases.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.